BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15827969)

  • 1. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
    Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
    J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Staack RF; Puetz M; Maurer HH
    J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of four thiophenethylamine designer drugs (2C-T-4, 2C-T-8, 2C-T-13, 2C-T-17) in human urine by capillary electrophoresis/mass spectrometry.
    Nieddu M; Boatto G; Pirisi MA; Dessì G
    Rapid Commun Mass Spectrom; 2010 Aug; 24(16):2357-62. PubMed ID: 20635321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry.
    Kerrigan S; Banuelos S; Perrella L; Hardy B
    J Anal Toxicol; 2011 Sep; 35(7):459-69. PubMed ID: 21871155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of new thioamphetamine designer drugs in plasma by capillary electrophoresis coupled with mass spectrometry.
    Boatto G; Nieddu M; Pirisi MA; Dessì G
    Rapid Commun Mass Spectrom; 2007; 21(22):3716-20. PubMed ID: 17955568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Fehn S; Maurer HH
    J Mass Spectrom; 2005 Jan; 40(1):105-16. PubMed ID: 15643651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry.
    Nieddu M; Boatto G; Pirisi MA; Baralla E
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3051-6. PubMed ID: 19705383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection.
    Boatto G; Nieddu M; Dessì G; Manconi P; Cerri R
    J Chromatogr A; 2007 Aug; 1159(1-2):198-202. PubMed ID: 17098243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry.
    Gunnar T; Ariniemi K; Lillsunde P
    J Mass Spectrom; 2005 Jun; 40(6):739-53. PubMed ID: 15806585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
    Ammann D; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-beta- phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1509-19. PubMed ID: 17103384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
    Theobald DS; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):374-7. PubMed ID: 16978931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection.
    Boatto G; Nieddu M; Carta A; Pau A; Palomba M; Asproni B; Cerri R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):93-8. PubMed ID: 15607712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection.
    Tsai CC; Liu JT; Shu YR; Chan PH; Lin CH
    J Chromatogr A; 2006 Jan; 1101(1-2):319-23. PubMed ID: 16325192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-beta-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):76-90. PubMed ID: 16600701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.